Healthcare Services company Thyrocare Technologies announced Q1FY27 results Standalone Financial Highlights: Total Revenue for Q1FY27 stood at Rs 229.17 crore, representing a YoY increase of 25.33% from Rs 182.85 crore in Q1FY26 and a QoQ growth of 6.89% from Rs 214.39 crore in Q4FY26. Revenue from operations reached Rs 225.66 crore in Q1FY27, reflecting a growth of 26.14% compared to Rs 178.89 crore in Q1FY26 and an increase of 7.11% against Rs 210.67 crore in Q4FY26. Other Income for Q1FY27 was Rs 3.51 crore, a decrease of 11.36% YoY from Rs 3.96 crore in Q1FY26 and a decrease of 5.65% QoQ from Rs 3.72 crore in Q4FY26. Profit after tax reached Rs 50.17 crore in Q1FY27, marking a YoY growth of 39.17% from Rs 36.05 crore in Q1FY26 and a QoQ increase of 15.12% from Rs 43.58 crore in Q4FY26. Total comprehensive income for the period was Rs 50.65 crore in Q1FY27, up by 41.32% YoY from Rs 35.84 crore in Q1FY26 and up 14.96% QoQ from Rs 44.06 crore in Q4FY26. Consolidated Financial Highlights: Total Revenue for Q1FY27 was Rs 244.17 crore, a YoY growth of 23.52% compared to Rs 197.68 crore in Q1FY26 and a QoQ increase of 6.97% from Rs 228.26 crore in Q4FY26. Revenue from operations in Q1FY27 stood at Rs 240.02 crore, showing a YoY growth of 24.34% from Rs 193.03 crore in Q1FY26 and a QoQ growth of 7.18% from Rs 223.95 crore in Q4FY26. Other Income for the quarter was Rs 4.15 crore, down from Rs 4.65 crore in Q1FY26 (YoY) and Rs 4.31 crore in Q4FY26 (QoQ). Net profit for the period (Profit for the period) reached Rs 51.33 crore in Q1FY27, reflecting a YoY increase of 34.06% from Rs 38.29 crore in Q1FY26 and a QoQ growth of 5.40% against Rs 48.70 crore in Q4FY26. Total comprehensive income for Q1FY27 was Rs 51.72 crore, representing a YoY increase of 35.89% from Rs 38.06 crore in Q1FY26 and a QoQ growth of 4.78% from Rs 49.36 crore in Q4FY26. Business Highlights Segment Performance (Diagnostic Testing Services): This segment recorded a revenue of Rs 226.21 crore in Q1FY27, reflecting a YoY growth of 26.85% from Rs 178.33 crore in Q1FY26 and a QoQ increase of 7.61% from Rs 210.22 crore in Q4FY26. Segment results (Profit before tax, exceptional items, share of profit of associate, and interest) stood at Rs 61.90 crore in Q1FY27 compared to Rs 44.85 crore in Q1FY26. Segment Performance (Imaging Services): Revenue for this segment was Rs 13.48 crore in Q1FY27, compared to Rs 14.04 crore in Q1FY26 and Rs 12.48 crore in Q4FY26. Segment results significantly improved to Rs 1.26 crore in Q1FY27 from Rs 0.27 crore in Q1FY26. Segment Performance (Others): Revenue for the "Others" segment was Rs 0.33 crore in Q1FY27, as against Rs 0.66 crore in Q1FY26 and Rs 1.25 crore in Q4FY26. Board Decisions: The Board approved the re-appointment of M/s. Ernst & Young LLP, Chartered Accountants, as the Internal Auditors of the Company for the financial year FY27. Stock Options: During Q1FY27, the company forfeited 3,733 equity stock options due to the discontinuance of services of certain employees. These options have been added back to the pool for future distribution. Total Assets and Liabilities: Consolidated total segment assets stood at Rs 833.10 crore as of Q1FY27 compared to Rs 737.60 crore in Q1FY26. Total liabilities reached Rs 190.14 crore in Q1FY27. Rahul Guha, MD & CEO, Thyrocare Technologies, said: “Thyrocare reported a strong performance this quarter, driven by continued focus on operational efficiency, network expansion, and value-driven diagnostics. During the period, we also strengthened our specialty portfolio with the addition of allergy testing and entry into genomics through the launch of NIPT, with a phased expansion of the test menu underway. Thyrocare continues to expand its reach in underserved regions and scale its franchise and partner network, while remaining committed to delivering high-quality, affordable healthcare services across India.” Result PDF